drugset / Trial / NCT02900742

Clinical Study of Chinese Medicine Plus Chemotherapy Maintenance in Advanced Non Small Cell Lung Cancer

NCT02900742

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The investigators performed a randomized, prospective study method on observation of Traditional Chinese Medicine(TCM) combined with chemotherapy maintenance to prolong the efficacy of long-term survival of advanced non small cell lung cancer(NSCLC) patients.The investigators plan to involve 100 cases for observation in 3 years (50 cases for chemotherapy maintenance, 50 cases for chemotherapy maintenance plus TCM), expecting that integrated TCM combined with chemotherapy maintenance has a better efficacy on prolonging progression-free survival time, overall survival, improving quality of life(QOL) of patients than that of chemotherapy maintenance.

Timeline

Start
2013-03
Primary completion
2016-12-30
Completion
2017-06-01

Drugs

EvaluationDrugModalityDoseRoute
Subject YangYinFang Unknown Oral
Subject YiQiFang Unknown Oral
Subject YiQiYangYinFang Unknown Oral
Background Docetaxel Small molecule 75 mg/m2 Intravenous
Background Gemcitabine Small molecule 1250 mg/m2 Intravenous
Background Pemetrexed Small molecule 500 mg/m2 Intravenous

Indications